Intrexon | XON - Interest Expense On Debt

Intrexon reported $637K in Interest Expense on Debt for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
Agenus AGEN:US USD 17.32M 1.72M
Amgen AMGN:US USD 415M 47M
Bristol Myers Squibb BMY:US USD 294M 5M
Gilead Sciences GILD:US USD 227M 2M
Immunogen IMGN:US USD 971K 104K
Intrexon XON:US USD 637K 1.4M
Karyopharm Therapeutics KPTI:US USD 5.88M 229K
Mannkind MNKD:US USD 5.29M 9K
Novartis NOVN:VX USD 219M 4M
Peregrine Pharmaceuticals PPHM:US USD 620K 83K
Roche Holding ROG:VX 348M 92M
Thermo Fisher Scientific TMO:US USD 269M 96M
Veracyte VCYT:US USD 5K 56K
YTE INCY:US USD 667K 26K
Ziopharm Oncology ZIOP:US USD 888K 47K